Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

320 questions · 333 findings · 159 reviews

No studies found 104 · 31.2%GRADE not reported 44 · 13.2%Very low 66 · 19.8%Low 57 · 17.1%Moderate 45 · 13.5%High 17 · 5.1%

Intervention not reported

Disease‐specific quality of life QUALEFFO‐41 total score Scale from 0 to 100 Lower scores indicate better quality of life · individuals with osteoporotic vertebral fracture
1 finding from 1 review

Intervention not reported

Changes in health‐related quality of life · lower limb arterial surgery

The review found no eligible studies for this question.

1 finding from 1 review

Serotonin and noradrenaline reuptake inhibitors (SNRI) vs placebo

Self‐reported health‐related quality of life (0‐100 scale) Higher scores indicate higher burden of disease (lower quality of life) · patients with fibromyalgia

Serotonin noradrenaline reuptake inhibitors showed no clear difference in self‐reported health‐related quality of life (0‐100 scale) Higher… compared with placebo (low certainty).

1 finding from 1 review

Doxycycline vs prednisolone

Quality of life (DLQI) adjusted for baseline DLQI, disease severity, age, Karnovsky score, baseline versus week 52. A lower score is more favourable. · bullous pemphigoid
1 finding from 1 review

Yoga vs an active intervention

Bothersomeness of symptoms at short term (6 weeks) Measured by the Overactive Bladder Symptom and Quality of Life‐Short Form (OABq‐SF) (lower = better) · women with urge‐predominant urinary incontinence
1 finding from 1 review

Intervention not reported

Health‐related quality of life (disease‐specific) Scale from 0 to 100; lower score indicates better HRQoL. SGRQ total score consists of weighted scores from 3 domains · individuals with stable bronchiectasis
1 finding from 1 review

Etanercept vs placebo

CDLQI Scores range from 0 to 30. Lower scores indicate better health‐related quality of life. Calculations are based on the change from baseline to week 12 in both groups · people with paediatric psoriasis
1 finding from 1 review